Dr. Ronan Glynn:

That is the same across all age cohorts. Equally, all people aged 60 or older who have received a first dose should receive the second dose as planned after 12 weeks. For all people under 60 years of age who have received a first dose and are not high risk or very high risk, the second dose should be deferred until 16 weeks after the first. Those people then will not be due to get their second dose for approximately another five or six weeks. That will give NIAC further time to consider whether an alternative strategy might be more appropriate and whether that would involve, for example, giving a different vaccine as a second dose. It is important to point out that 800,000 second doses of AstraZeneca have been given to date in the UK with no negative outcomes. It may be, therefore, that this issue which has been identified is something that shows itself after a first dose as opposed to after a second. As I said, however, the next few weeks will allow us to further assess that and come back with updated recommendations.